Search

Supplemental material, sj-docx-1-his-10.1177_11786329231183317 for Identifying Unique Subgroups of High-Cost Patients With Schizophrenia: A Population-Based Study Using Latent Class Analysis by Andrew J Stewart, Scott B Patten, Kirsten M Fiest, Tyler S Williamson, James P Wick and Paul E Ronksley in Health Services Insights

Supplemental material, sj-docx-3-his-10.1177_11786329231183317 for Identifying Unique Subgroups of High-Cost Patients With Schizophrenia: A Population-Based Study Using Latent Class Analysis by Andrew J Stewart, Scott B Patten, Kirsten M Fiest, Tyler S Williamson, James P Wick and Paul E Ronksley in Health Services Insights

Supplemental material, sj-docx-2-his-10.1177_11786329231183317 for Identifying Unique Subgroups of High-Cost Patients With Schizophrenia: A Population-Based Study Using Latent Class Analysis by Andrew J Stewart, Scott B Patten, Kirsten M Fiest, Tyler S Williamson, James P Wick and Paul E Ronksley in Health Services Insights

Supplemental material, sj-docx-3-cpa-10.1177_07067437221082885 for 10-Year Trends in Healthcare Spending among Patients with Schizophrenia in Alberta, Canada by Andrew J. Stewart, Scott B. Patten, Kirsten M. Fiest, Tyler S. Williamson, James P. Wick and Paul E. Ronksley in The Canadian Journal of Psychiatry

Supplemental material, sj-docx-4-cpa-10.1177_07067437221082885 for 10-Year Trends in Healthcare Spending among Patients with Schizophrenia in Alberta, Canada by Andrew J. Stewart, Scott B. Patten, Kirsten M. Fiest, Tyler S. Williamson, James P. Wick and Paul E. Ronksley in The Canadian Journal of Psychiatry

Supplemental material, sj-docx-2-cpa-10.1177_07067437221082885 for 10-Year Trends in Healthcare Spending among Patients with Schizophrenia in Alberta, Canada by Andrew J. Stewart, Scott B. Patten, Kirsten M. Fiest, Tyler S. Williamson, James P. Wick and Paul E. Ronksley in The Canadian Journal of Psychiatry

Supplemental material, sj-docx-1-cpa-10.1177_07067437221082885 for 10-Year Trends in Healthcare Spending among Patients with Schizophrenia in Alberta, Canada by Andrew J. Stewart, Scott B. Patten, Kirsten M. Fiest, Tyler S. Williamson, James P. Wick and Paul E. Ronksley in The Canadian Journal of Psychiatry

Additional file 1:.

Supplemental material, CJKHD_Supplemental_Material_-_Appendix_1-3_Revised_Clean_Copy_-_June_29_2020_1 for Derivation and Internal Validation of a Clinical Risk Prediction Tool for Hyperkalemia-Related Emergency Department Encounters Among Hemodialysis Patients by Paul E. Ronksley, James P. Wick, Meghan J. Elliott, Robert G. Weaver, Brenda R. Hemmelgarn, Andrew McRae, Matthew T. James, Tyrone G. Harrison and Jennifer M. MacRae in Canadian Journal of Kidney Health and Disease

Importance: Although patients with chronic kidney disease (CKD) are routinely managed in primary care settings, no nationally representative study has assessed the quality of care received by these patients in Canada. Objective: To evaluate the current state of CKD management in Canadian primary care practices to identify care gaps to guide development and implementation of national quality improvement initiatives. Design, Setting, and Participants: This cross-sectional study leveraged Canadian Primary Care Sentinel Surveillance Network data from January 1, 2010, to December 31, 2015, to develop a cohort of 46 162 patients with CKD managed in primary care practices. Data analysis was performed from August 8, 2018, to July 31, 2019. Main Outcomes and Measures: The study examined the proportion of patients with CKD who met a set of 12 quality indicators in 6 domains: (1) detection and recognition of CKD, (2) testing and monitoring of kidney function, (3) use of recommended medications, (4) monitoring after initiation of angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin II receptor blockers (ARBs), (5) management of blood pressure, and (6) monitoring for glycemic control in those with diabetes and CKD. The study also analyzed associations of divergence from these quality indicators. Results: The cohort comprised 46 162 patients (mean [SD] age, 69.2 [14.0] years; 25 855 [56.0%] female) with stage 3 to 5 CKD. Only 4 of 12 quality indicators were met by 75% or more of the study cohort. These indicators were receipt of an outpatient serum creatinine test within 18 months after confirmation of CKD, receipt of blood pressure measurement at any time during follow-up, achieving a target blood pressure of 140/90 mm Hg or lower, and receiving a hemoglobin A1c test for monitoring diabetes during follow-up. Indicators in the domains of detection and recognition of CKD, testing and monitoring of kidney function (specifically, urine albumin to creatinine ratio testing), use of recommended medications, and appropriate monitoring after initiation of treatment with ACEIs or ARBs were not met. Only 6529 patients (18.4%) with CKD received a urine albumin test within 6 months of CKD diagnosis, and 3954 (39.4%) had a second measurement within 6 months of an abnormal baseline urine albumin level. Older age (≥85 years) and CKD stage 5 were significantly associated with not satisfying the criteria for the quality indicators across all domains. Across age categories, younger patients (aged 18-49 years) and older patients (≥75 years) were less likely to be tested for albuminuria (314 of 1689 patients aged 18-49 years [18.5%], 1983 of 11 919 patients aged 75-84 years [61.6%], and 614 of 5237 patients aged ≥85 years [11.7%] received the urine albumin to creatinine ratio test within 6 months of initial estimated glomerular filtration rate

Background: Electronic personal health records (ePHRs) provide patients with access to their personal health information, aiming to inform them about their health, enhance self-management, and improve outcomes. Although they have been associated with improved health outcomes in several chronic diseases, the potential impact of ePHR use in chronic kidney disease (CKD) is unknown. Objectives: We sought to understand perceptions of CKD patients about ePHRs, and describe characteristics associated with their expressed intent to use an ePHR. Design: Self-administered paper based survey. Setting: The study was conducted in Calgary, Alberta, Canada at a multidisciplinary CKD clinic from November 2013 to January 2014. Participants: Patients with non-dialysis-dependent CKD. Measurements: Demographics, perceived benefits, and drawbacks of ePHRs were obtained. A univariate analysis was used to assess for an association with the expressed intention to use an ePHR. Methods: A patient survey was used to determine perceptions of ePHRs, and to identify factors that were associated with intention to use an ePHR. Results: Overall 63 patients with CKD (76.2 % male, 55.6 % ≥65 years old) completed the survey. The majority (69.8 %) expressed their intent to use an ePHR. CKD patients over the age of 65 were less likely to intend to use an ePHR as compared to those aged